← Back to directory

Nam H. Dang

Researcher Next ID · RN-028907

Researcher · Medicine

University of Florida

Gainesville, Vietnam

Not currently recruitingFunding unknown
Works count
267
Citation count
10,535
H-index
55
i10-index
145

Research interests

Medicine
Peptidase Inhibition and Analysis
Lymphoma Diagnosis and Treatment
Chronic Lymphocytic Leukemia Research
Monoclonal and Polyclonal Antibodies Research
Cell Adhesion Molecules Research

Publications

  • Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32984-2

  • High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine

    Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.01.1825

  • Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

    Journal of Clinical Oncology · 2004 · https://doi.org/10.1200/jco.2005.03.108

Current projects

    No projects listed.